Cardiac Vascular Nursing Exam Risk Assessment & Management 3 — Questions and Answers
Question 1: A patient is admitted with a non-ST-elevation myocardial infarction (NSTEMI). Which TIMI risk score finding carries the most weight in predicting 14-day adverse outcomes?
- Age 55–64 years
- ST deviation ≥0.5 mm on presenting ECG (Correct answer)
- Single coronary artery risk factor
- Aspirin use in prior 7 days
Correct answer: ST deviation ≥0.5 mm on presenting ECG
ST deviation ≥0.5 mm is heavily weighted in the TIMI risk score as it reflects significant myocardial ischemia and predicts adverse outcomes.
Question 2: Which patient characteristic most significantly increases the risk of heparin-induced thrombocytopenia (HIT) in a cardiac unit?
- Female gender over age 70
- Post-cardiac surgery patient receiving unfractionated heparin for >4 days (Correct answer)
- Patient on low-molecular-weight heparin for DVT prophylaxis for 2 days
- Patient with chronic kidney disease receiving heparin flushes only
Correct answer: Post-cardiac surgery patient receiving unfractionated heparin for >4 days
Post-cardiac surgery patients exposed to unfractionated heparin for more than 4 days have the highest incidence of HIT due to platelet factor 4 antibody formation.
Question 3: When using the 4T scoring system to assess HIT risk, a score of 6–8 indicates:
- Low probability of HIT — continue heparin
- Intermediate probability — send HIT antibody panel only
- High probability — stop heparin and start alternative anticoagulation immediately (Correct answer)
- Confirmed HIT — initiate platelet transfusion
Correct answer: High probability — stop heparin and start alternative anticoagulation immediately
A 4T score of 6–8 represents high clinical probability for HIT, requiring immediate cessation of heparin and initiation of a non-heparin anticoagulant such as argatroban.
Question 4: A 72-year-old woman with heart failure (EF 30%) is being evaluated for ICD implantation. Which condition must be optimized for at least how many months before reassessing EF eligibility?
- 1 month of optimal medical therapy
- 3 months of guideline-directed medical therapy (Correct answer)
- 6 months of diuretic therapy alone
- No waiting period — implant immediately
Correct answer: 3 months of guideline-directed medical therapy
Current guidelines recommend at least 3 months of guideline-directed medical therapy (GDMT) before reassessing EF, as EF may improve with optimization.
Question 5: Which laboratory value is the most sensitive early marker for acute kidney injury following cardiovascular surgery?
- Serum creatinine
- Blood urea nitrogen (BUN)
- Serum cystatin C (Correct answer)
- Urine specific gravity
Correct answer: Serum cystatin C
Cystatin C rises within 24 hours of AKI, making it more sensitive than creatinine, which may not rise for 48–72 hours after renal injury.
Question 6: A patient on warfarin for mechanical heart valve presents with an INR of 1.6 prior to an elective colonoscopy. What is the most appropriate bridging strategy?
- Hold warfarin and proceed without bridging
- Hold warfarin and bridge with therapeutic low-molecular-weight heparin (Correct answer)
- Continue warfarin at the current dose
- Switch permanently to a direct oral anticoagulant
Correct answer: Hold warfarin and bridge with therapeutic low-molecular-weight heparin
Patients with mechanical heart valves have high thromboembolic risk and require therapeutic LMWH bridging when warfarin is interrupted for procedures.
Question 7: A 65-year-old male smoker with hypertension is found to have a 4.8 cm abdominal aortic aneurysm on routine ultrasound. What is the recommended management?
- Emergent surgical repair
- Elective endovascular repair (EVAR) within 2 weeks
- Surveillance ultrasound every 6–12 months and risk factor modification (Correct answer)
- No further follow-up needed as it is below surgical threshold
Correct answer: Surveillance ultrasound every 6–12 months and risk factor modification
Aneurysms between 4.0–5.4 cm are monitored with serial ultrasound every 6–12 months while aggressively managing cardiovascular risk factors.
A patient is admitted with a non-ST-elevation myocardial infarction (NSTEMI).
Which TIMI risk score finding carries the most weight in predicting 14-day adverse outcomes?